Headlines

заголовки анонсы
03.10.2026
00:41 Bioengineer.org AI Shows Striking Accuracy in Diagnosing Chronic Ankle Instability, Review Finds

Ankle sprains are among the most common musculoskeletal injuries on the planet, and for a stubborn minority of patients they never truly heal. Roughly a quarter of people who sprain an ankle go on to develop chronic ankle instability, a condition defined by repeated episodes of the joint giving way, lingering mechanical laxity, and long-term […]

Скрыть анонс
00:27 Bioengineer.org New computational benchmark reveals how closely lab-grown embryo models match real human development

For years, scientists have grown ball-like structures from human stem cells that mimic some of the earliest stages of embryonic life, hoping to unlock the secrets of fertility, pregnancy loss and developmental disease without relying on donated human embryos. These structures, known as blastoids, have become one of the most promising and most debated tools […]

Скрыть анонс
00:13 Bioengineer.org Injectable Microspheres Deliver Regenerative Nanovesicles to Rebuild Soft Tissue

Soft tissue defects caused by trauma, tumor removal, or congenital conditions remain one of the most stubborn challenges in reconstructive medicine. Fat grafts shrink, synthetic fillers eventually fade, and engineered tissues often fail to develop the blood supply they need to survive. Now, a team of researchers reporting in the Journal of Advanced Research has […]

Скрыть анонс
02.10.2026
22:57 GenEngNews.com FDA to Highlight Aging, Longevity Medicine in Planned FARS Update

FDA Chief Scientist Steven Kozlowski, MD, said the updated FARS would come out early in FY 2027 but offered no further specifics on timing. The post FDA to Highlight Aging, Longevity Medicine in Planned FARS Update appeared first on GEN - Genetic Engineering and Biotechnology News.

Скрыть анонс
22:12 DiscoverMagazine.com An Update on the Perseverance Rover, a Cold War Satellite Explodes Above Earth, and Gene-Edited Bananas Stay Yellow Longer

Discover the top stories from Sept. 26 to Oct. 2, 2026, including an update on the Perseverance Rover's search for life on Mars and a gene-edited banana could be on our grocery shelves soon.

Скрыть анонс
20:53 Bioengineer.org AI Reads CT Scans and Blood Tests to Spot Elusive Gut Tumors Before Surgery

A team of researchers in China has built a machine learning system that can identify gastrointestinal stromal tumors, one of the most easily missed cancers of the digestive tract, by combining the subtle shapes hidden inside CT scans with routine blood test results. The study, published in Holistic Integrative Oncology, reports that the best models […]

Скрыть анонс
19:12 MedicalXpress.com Lab‑grown 'mini‑bladder' helps explain why urinary tract infections keep coming back

For many people, a urinary tract infection (UTI) doesn't really end when the antibiotics run out. The burning and constant trips to the bathroom fade, then return weeks or months later.

Скрыть анонс
18:44 Bioengineer.org Gut Microbes From Elderly Humans Weaken Intestinal Barriers When Transplanted Into Pigs

The trillions of microbes living in the human gut change dramatically as we age, and a growing body of research suggests those changes are not merely a byproduct of getting old but active participants in the decline of intestinal health. A new study published in Aging Cell has taken one of the most direct approaches […]

Скрыть анонс
18:34 SeekingAlpha.com Pandora's lab-grown diamonds; Vietnam facility to drive growth

Скрыть анонс
18:30 MedicalXpress.com Stem cell-derived brain models offer a new window into how anesthesia works

Every day, hundreds of thousands of people undergo general anesthesia, trusting they'll drift into unconsciousness and wake safely after surgery. Yet despite decades of use, scientists still don't fully understand how anesthetic drugs reshape the brain's electrical activity to produce unconsciousness.

Скрыть анонс
18:03 Phys.org First U.S. tomato spotted wilt virus clone could speed development of disease-resistant crops

New technology from Texas A&M AgriLife Research could be a major step toward bringing disease-resistant peppers and tomatoes to growers' fields and lowering costs at grocery stores.

Скрыть анонс
18:03 Phys.org A 'reality check' for lab-grown human embryo models

University of Sydney researchers have developed a new way to test how closely lab-grown biological models resemble real human embryos, finding that while some models perform well, none yet fully capture the complexity of early human development.

Скрыть анонс
17:48 Bioengineer.org Pork Gelatin Emerges as the Best Bio-Ink for 3D-Printed Cultured Meat Scaffolds

The future of lab-grown steak may hinge on an unexpectedly humble ingredient: gelatin powder. In a new open-access study published in Food Science of Animal Resources, researchers at Kongju National University and the National Institute of Animal Science in South Korea systematically compared bio-inks made from beef, pork, and fish gelatin, testing how the source […]

Скрыть анонс
17:34 Bioengineer.org New Nomogram Predicts Deadly Transplant Complication in High-Risk Leukemia Patients

For patients battling high-risk or refractory acute leukemia, an allogeneic hematopoietic stem cell transplant is often the last, best hope for a cure. The procedure replaces a patient’s diseased bone marrow with healthy blood-forming stem cells from a donor, rebooting the immune system and the blood itself. Yet the treatment carries a sobering paradox: some […]

Скрыть анонс
17:20 Bioengineer.org AI Reads Scans to Predict Hidden Spread in Colorectal Cancer Before Surgery

One of the most consequential questions in colorectal cancer care is also one of the hardest to answer before a scalpel touches the patient: has the tumor already sent cells creeping into the lymphatic or blood vessels that thread through the bowel wall? This phenomenon, known as lymphovascular invasion, or LVI, is invisible to the […]

Скрыть анонс
15:20 BMJ.com RFK Jr: AI can give a second opinion better “than any doctor in the country”

AI “has the capacity to dominate us to free us from medical tyranny” US health secretary Robert F Kennedy Jr has claimed.1“It can give you a second opinion that is much better informed than any doctor in the country,” Kennedy told a Make America Healthy Again summit earlier this week.2Kennedy quoted Sam Altman, OpenAI’s chief executive, who reportedly told him in a private meeting days before that it would be “malpractice for a doctor to make a diagnosis or to make a prescription without at least checking AI.”“One of the things that is going to change is that we’re never ever again gonna be dominated by public officials who tell us ‘trust the experts,’” Kennedy said.“If somebody tells you, ‘Masks work, trust the experts,’ AI may tell you otherwise. If somebody tells you, ‘Social distancing works, trust the experts,’ AI may correct that. And if somebody tells you that a...

Скрыть анонс
14:38 Technology.org Tokyo Court Rules Human Voices Are Protected From AI Cloning

Japan Recognizes Voice Rights Kenjiro Tsuda left a Tokyo courtroom without the order he asked for, and with

Скрыть анонс
13:55 Bioengineer.org Mouth Ulcers, Not Old Dental Infections, Drive Fever After Stem Cell Transplants

Fever is one of the most common and most worrying events in the weeks following a hematopoietic cell transplantation, the procedure in which patients with blood cancers such as multiple myeloma, acute myeloid leukemia, and lymphoma receive an infusion of blood-forming stem cells after intensive conditioning chemotherapy. In many of these patients, a temperature spike […]

Скрыть анонс
13:41 FightAging.org Where Next For Present Stem Cell Therapies?

First generation stem cell therapies have become widespread; they are readily accessed in medical tourism clinics, and are also available for a range of issues in more regulated parts of the world. Initially it was hoped that transplanted cells would engraft and survive to assist tissues in repair and regeneration, but it has become clear that this is not how the therapies produce benefits. Rather it is a matter of signals generated by the transplanted cells in the short time they survive that beneficially alter the behavior of native cells. Unfortunately, while effects such as months-long suppression of chronic inflammation are fairly reliable, other hoped for improvements such as the stimulation of greater regeneration or regression of disease remain highly unreliable outcomes. One might ask […]

Скрыть анонс
13:28 FightAging.org Polyamines from the Gut Microbiome Affect Life Span in Flies

The commensal microbes of the gut microbiome generate a range of metabolites that are beneficial or necessary to cell function. Levels of a number of these metabolites have been shown to decline with age as the composition of the gut microbiome changes for the worse. Overall the gut microbiome clearly makes a meaningful contribution to health and longevity, as demonstrated by the sizeable benefits resulting from providing a young microbiome to an old animal, but it isn't clear as to how much of these effects derive from changes in the production of any specific metabolite. Metabolites produced by gut bacteria are taken up by the host and have a direct impact on its health. However, to our knowledge, no studies have investigated the effects of […]

Скрыть анонс
13:05 SeekingAlpha.com LifeX 2065 Longevity Income ETF declares $0.8333 dividend

Скрыть анонс
12:48 Bioengineer.org Gene-edited yeast turns fermentation vats into carotenoid factories

Carotenoids are everywhere in our lives, even if most of us never notice them. They are the pigments that make tomatoes red, carrots orange, and salmon pink, and they are also some of the most valuable molecules in the food, cosmetic, and pharmaceutical industries. A new review published in Blue Biotechnology by Neha Arora of […]

Скрыть анонс
12:35 Arxiv.org CS Quantum Secret Sharing and Error Correction vs No-Cloning

arXiv:2610.00441v1 Announce Type: cross Abstract: Secret sharing is ubiquitous throughout cryptography. All possible access structures are classically feasible, and in the case of threshold access structures, the protocols are even very efficient. However, when moving to the quantum setting, the no-cloning theorem shows that many access structures are impossible. In fact, no-cloning exactly characterizes feasibility: for thresholds, quantum secret sharing is possible if and only if the threshold $t$ is strictly more than $n/2$. In this work, we propose a variant of quantum secret sharing (QSS) where two or more identical copies of the input state are provided, but the output is only required to recover one copy. This notion circumvents the simple one-copy no-cloning obstruction, though the natural $k$-copy generalization still gives much milder obstructions. For thresholds using $k$ copies, no-cloning implies that QSS is impossible whenever $t\leq n/(k+1)$. It is tempting to

Скрыть анонс
12:34 Bioengineer.org Sex Chromosomes Direct Cancer, Heart Health, and Longevity

For decades, the scientific consensus has maintained that the primary drivers of health disparities between men and women are circulating sex hormones, specifically estrogen and testosterone. While these hormones undoubtedly play a critical role in physiology, a comprehensive new review published in the journal Science challenges this singular focus. The research demonstrates that the X […]

Скрыть анонс
12:07 Bioengineer.org Smarter Classifiers, Not Flashier Attention, Drive Gains in Drug-Target AI

Predicting whether a drug molecule will bind to a particular protein target is one of the most consequential questions in computational drug discovery, and deep learning models have promised to answer it at scale. Yet a persistent problem has haunted the field: when a new model reports better numbers than its predecessor, it is often […]

Скрыть анонс
11:25 Labiotech.eu How Flagship’s Valo is reshaping AI drug discovery with human data

AI has been one of the biggest buzzwords in biotech for years now but actual R&D productivity gains have been hard to find. My guest today believes that's because AI alone was never going to be the answer. The post How Flagship’s Valo is reshaping AI drug discovery with human data appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Скрыть анонс
08:42 Bioengineer.org Melatonin’s Healing Power May Run Through One Ancient Longevity Enzyme

Melatonin is best known as the hormone that tells the body it is time to sleep, secreted by the pineal gland in darkness and sold over the counter as a jet-lag remedy. But a new review published in Molecular Biology Reports argues that this small indoleamine molecule, N-acetyl-5-methoxytryptamine, does far more than regulate circadian rhythm. […]

Скрыть анонс
07:48 CNBC top news Jewelry giant Pandora is getting on lab-grown diamonds and hoping a new Vietnam plant helps growth in Asia

Pandora is expanding its manufacturing footprint beyond Thailand with a new $150 million Vietnam facility as the Danish jeweler eyes further growth across Asia.

Скрыть анонс
04:13 Bioengineer.org Bangladesh’s AI Medical Imaging Boom Is Outpacing Its Laws, Study Warns

Artificial intelligence is quietly rewriting the rules of diagnostic medicine, and nowhere is the tension between technological promise and legal preparedness more visible than in Bangladesh. A new doctrinal study published in Discover Artificial Intelligence examines how the country’s legal and ethical frameworks are coping with the rapid arrival of AI-powered medical imaging tools, and […]

Скрыть анонс
04:13 MedicalXpress.com First successful primate transplant of human pituitary tissue boosts cortisol levels

Researchers in Japan have transplanted pituitary tissue grown from human stem cells into a primate whose pituitary gland had been surgically removed, successfully restoring critical hormone signals. Led by researchers from Nagoya University in Japan, the team showed that the same method worked in mice over a longer period.

Скрыть анонс
03:59 Bioengineer.org Two Transplants, One Immune Rebuild: Letermovir Shields a Rare Immunodeficiency Case

A rare case report published in Annals of Hematology describes how a 19-year-old man with X-linked hyper-IgM syndrome, one of the most formidable inborn errors of immunity, survived a punishing sequence of two organ transplants and multiple opportunistic infections, emerging three years later with a fully rebuilt immune system and a functioning donor liver. The […]

Скрыть анонс
02:53 Bioengineer.org Old Breast Cancer Drug Ormeloxifene Pushes Tumor Cells Into Irreversible Senescence

A drug that millions of women have taken for decades as a once-a-week contraceptive may have a second, far more dramatic life in oncology. In a new study published in Molecular Biology Reports, researchers at CSIR-Central Drug Research Institute in Lucknow report that ormeloxifene, a non-steroidal selective estrogen receptor modulator long used clinically in India […]

Скрыть анонс
02:40 Bioengineer.org Compact AI Network Blends Mamba and Polynomial Neurons for Medical Image Segmentation

Medical image segmentation, the task of tracing the exact outlines of lesions, polyps, and blood vessels in clinical scans, has long been dominated by a trade-off. Convolutional networks excel at capturing fine local detail but struggle to connect distant regions of an image, while transformer-based models reason globally at a steep computational price. A new […]

Скрыть анонс
02:26 Bioengineer.org Histone Chaperone NAP1L1 Keeps Gene Expression Steady in Stem Cells

Embryonic stem cells are famous for their potential, but they are equally remarkable for their restlessness. In a culture dish of seemingly identical mouse embryonic stem cells, the levels of key pluripotency factors can swing dramatically from one cell to the next, even when the cells share the same genome and the same growth medium. […]

Скрыть анонс
02:12 Bioengineer.org EU Adopts Landmark Rules for Gene-Edited Plants After Two-Decade Wait

After nearly two decades of scientific debate, political wrangling and technological revolution, the European Union has finally rewritten the rules governing the newest generation of plant breeding. On 17 June 2026, with the approval of both the European Council and the European Parliament, Regulation (EU) 2026/1388 on plants obtained by certain new genomic techniques and […]

Скрыть анонс
01:59 Bioengineer.org Vaccine Responses Hold Up a Year After Stem Cell Transplants, Study Finds

Patients who undergo allogeneic haematopoietic stem cell transplantation, in which blood-forming stem cells come from a donor rather than the patient, face a persistent immunological dilemma. The conditioning chemotherapy and immunosuppressive drugs required to prevent graft-versus-host disease strip away much of the immune memory a person has built over a lifetime, leaving transplant recipients unusually […]

Скрыть анонс
00:53 Bioengineer.org Inducible dCas12a tool widens CRISPR gene control in malaria parasite

Malaria remains one of humanity’s most stubborn infectious diseases, claiming more than 600,000 lives in 2024, with the vast majority of deaths caused by a single parasite: Plasmodium falciparum. Despite decades of research, roughly half of the more than 5,000 genes encoded in the parasite’s genome still lack any functional annotation, and resistance to front-line […]

Скрыть анонс
00:52 MedicalXpress.com 'Mini-brains' model myelin damage and regeneration, offering new tool for MS drug testing

Researchers have developed 3D "mini-brains" they hope will help speed up the search for much-needed drug treatments for multiple sclerosis (MS), an autoimmune condition affecting almost 3 million people worldwide. Their research has been published in the journal Nature Neuroscience.

Скрыть анонс
00:08 GenEngNews.com Talus Bio’s Structure-Free AI Model Targets Unstructured Proteins in Their Native Cellular Context

Intrinsically disordered proteins have resisted structure-based drug discovery because they lack a stable fold to model. Talus Bio's structure-free AI model sidesteps that limitation, targeting these proteins in their native environment instead of in isolation or from a predicted structure. The post Talus Bio’s Structure-Free AI Model Targets Unstructured Proteins in Their Native Cellular Context appeared first on GEN - Genetic Engineering and Biotechnology News.

Скрыть анонс
00:01 Phys.org Salivary gland mini-organs grown from pluripotent stem cells offer potential path to treating severe dry mouth

Extreme dry mouth, caused by radiation used to treat cancer and by autoimmune diseases such as Sjögren's disease, radically affects quality of life for sufferers. It can hamper speaking, swallowing and eating, and for years has seemed an intractable problem.

Скрыть анонс
01.10.2026
21:18 Science.org Longevity products: Innovation through regulation | Science

Longevity is taking off, but regulatory oversight is essential to determining what works—and what doesn’t

Скрыть анонс
21:18 Science.org Epistemic justice in gene-editing research | Science

HomeScienceVol. 394, No. 6819Epistemic justice in gene-editing researchBack To Vol. 394, No. 6819 Full accessLetter Share on Epistemic justice in gene-editing researchDong Dong, Yiou Wang, and Tao MaAuthors Info & AffiliationsScience1 Oct 2026Vol 394, Issue 6819p. 38 PREVIOUS ARTICLEWalden and the wild roots of conservation sciencePreviousNEXT ARTICLERecording results from single-patient trialsNe…

Скрыть анонс
21:18 Science.org Streamlining oversight in gene-editing trials | Science

In the News Feature “A fatal reaction” (23 July, 10.1126/science. aek8000), B. Borrell reports that a 6-year-old girl died after the world’s first-in-human brain base-editing trial in China. This case highlights a governance paradox: A regulatory system with detailed ethical rules failed to prevent a fatal outcome. Institutional fragmentation may be at fault. As countries expand access to highly individualized gene-editing therapies, they must also strengthen continuous, cross-institutional oversight.

Скрыть анонс
21:18 Science.org The utilitarian temptation in gene editing | Science

The recent gene-editing trial led by Zilong Qiu and colleagues in Shanghai (“A fatal reaction,” B. Borrell, News Feature, 23 July, 10.1126/science.aek8000) was not only a case of failed oversight; it also illustrates a recurring moral danger in biomedical research. Such trials can be driven by two mutually reinforcing motivations: the pursuit of professional recognition and a crude utilitarian rationale that risky experiments are justified because, if successful, they may benefit large numbers of present and future patients. This second motivation, which is especially powerful in biomedicine, can cloak self-interest in moral language and encourage researchers to discount evidence of danger to the individuals enrolled as subjects. Gene-editing interventions, in particular, may appear morally elevated because their promised benefits aim to enhance general welfare for all, including future generations, regardless of nationality or group identity. For this reason, the appeal to future

Скрыть анонс
21:16 FightAging.org Healthspan May Not Be a Usefully Robust Metric for Progress in Rejuvenation Biotechnology

The effects of calorie restriction and even larger effects of growth hormone receptor knockout on the lifespan of mice have proven to be hard to beat. In large part, this is because (a) aging is the result of a number of very different causes, (b) producing comprehensive rejuvenation will require a number of very different therapies applied in combination, and (c) next to no-one is assessing the results of combination therapies targeting the root causes of aging. One of the other consequences of aging having multiple distinct (but interacting) causes is that it is in principle possible to make good progress on treating a cause of aging without producing an appreciable gain in healthspan or lifespan, or without reversing a given class of age-related disease, […]

Скрыть анонс
19:26 Bioengineer.org New AI Framework Spots Doctored Videos by Reading Both Space and Time

Video has never been easier to fake. Consumer editing suites can duplicate a frame, splice in footage from another clip, or use inpainting algorithms to erase a person from a scene entirely, and the compression pipelines of social media platforms then wash away many of the subtle artifacts that forensic investigators traditionally relied upon. A […]

Скрыть анонс
18:19 Healio.com Kidney transplant gap remains despite antidiscrimination laws

Many U.S. states have passed laws prohibiting disability-based discrimination, but patients with intellectual and developmental disabilities continue to face disparities in access to kidney transplants, according to study data.The first law protecting organ transplant recipients from disability-based discrimination was passed in 1996 under a revision to California’s Uniform Anatomical Gifts Act, according to study background. Thirty-nine states have followed with their own antidiscrimination legislation between 2013 and 2023, with two primary provisions established. The first provision

Скрыть анонс
17:13 MedicalDaily.com Early Mayo Clinic AI Model Flagged Pancreatic Cancer Risk Up to Three Years Before Diagnosis in Health Records

Mayo Clinic AI model flagged pancreatic cancer risk up to three years early using health records. The research is preliminary and not yet in use.

Скрыть анонс
15:40 IbTimes.co.uk Robert F. Kennedy Jr. Says That Artificial Intelligence Can Help 'To Free Us From Medical Tyranny'

At a Washington health summit, Robert F. Kennedy Jr argued that AI could offer better-informed medical opinions, but the article examines the technology's limits and political risks.

Скрыть анонс
15:08 Medscape.Com Peripheral Artery Disease Tied to Mortality Post-Transplant

Peripheral artery disease is associated with an increased risk for death in the first year after kidney transplant among patients aged 65 years or older, a French study finds.

Скрыть анонс
14:55 Bioengineer.org BK Virus Kidney Infection Shows Broad Immune Disruption in Transplant Patients

BK virus-associated nephropathy, a potentially devastating complication of kidney transplantation, has long been recognized as a disorder of immune balance: the immunosuppressive drugs that protect a transplanted kidney from rejection also blunt the antiviral defenses that normally keep this ubiquitous polyomavirus in check. A new study published in Virology Journal by Shuang Fei, Bowen Wang, […]

Скрыть анонс
14:30 MedicalDaily.com Huntington's Gene Therapy Still Appears to Slow Daily Function Decline at Four Years, but Main Score Misses Significance

Four-year AMT-130 data show a lasting daily function signal, but the main Huntington's score lost significance. What families should know.

Скрыть анонс
14:01 Bioengineer.org Sticky Gel Carrying Supercharged Stem Cell Vesicles Repairs Burned Esophagus in Rats

When a child or adult accidentally swallows a corrosive household chemical, the consequences can be devastating. The caustic substance strips away the lining of the esophagus, triggering a cascade of inflammation, tissue death, and ultimately scarring that narrows the swallowing tube into a rigid, dysfunctional channel. According to pooled clinical data cited by the researchers, […]

Скрыть анонс
13:47 Bioengineer.org Robotic Hip and Knee Replacements Show No Clear Advantage Over Conventional Surgery in Landmark UK Study

One of the largest real-world comparisons of surgical technology ever conducted has found that robotic-assisted hip and knee replacement surgery offers no clear benefit over conventional operations when it comes to the outcomes that matter most to patients and health systems. The findings, published in The BMJ by researchers analysing more than 1.3 million joint […]

Скрыть анонс
12:11 Bioengineer.org AI Maps the Abdomen in 13 Regions to Stage Cancer Without Surgery

For patients with peritoneal metastases—cancer that has spread to the lining of the abdominal cavity—one number can shape the entire course of treatment. That number is the peritoneal cancer index, or PCI, a score that surgeons calculate by dividing the abdomen into thirteen regions and grading the largest tumor deposit in each one. The problem […]

Скрыть анонс
11:57 Bioengineer.org AI Reads Routine Pathology Slides to Predict Cancer Biomarkers Across 12 Tumor Types

A routine tissue biopsy can now reveal far more than what a pathologist sees under the microscope. A team of researchers in China has developed an artificial intelligence system, called RIDGE, that predicts molecular biomarkers of cancer directly from ordinary hematoxylin and eosin stained pathology slides, the same glass slides prepared in every hospital laboratory […]

Скрыть анонс
11:43 Bioengineer.org Blood or skin? The starting cell may shape hidden DNA flaws in stem cell lines

Induced pluripotent stem cells have become one of the most powerful tools in modern biomedical research, offering scientists a way to rewind adult cells back into an embryonic-like state and then grow them into almost any tissue in the body. Yet the reprogramming process itself carries a hidden risk: it can introduce large-scale rearrangements of […]

Скрыть анонс
11:29 Bioengineer.org AI Learns to Read Hearing Tests Like an Audiologist, But Not Yet Like a Doctor

Hearing tests produce some of medicine’s most deceptively simple images. An audiogram is a grid of symbols marking the faintest sounds a patient can detect at each frequency, in each ear, with and without masking noise. A tympanogram traces how the eardrum moves under changing pressure. Interpreting these charts requires more than reading numbers: it […]

Скрыть анонс
11:29 Bioengineer.org Engineered Stem Cell Exosomes Offer a New Attack on Insulin Resistance

Insulin resistance sits at the root of some of the most burdensome diseases of modern life, including type 2 diabetes, non-alcoholic fatty liver disease, obesity, and metabolic syndrome. When skeletal muscle, adipose tissue, and the liver stop responding properly to circulating insulin, glucose uptake falters, lipid metabolism goes awry, and the pancreas compensates by pumping […]

Скрыть анонс
11:01 Bioengineer.org Algae, CRISPR and the Race to Turn Sunlight Into Fuel

Fossil fuels still supply roughly 80 percent of the world’s energy, and the consequences of that dependence are now impossible to ignore. Combustion of coal, oil and gas releases greenhouse gases, above all carbon dioxide, that accelerate global warming, drive sea-level rise and destabilize ecosystems on which human health depends. Meanwhile, demand keeps climbing: global […]

Скрыть анонс
09:16 Technology.org New Gene-Editing Method, ‘Prime Assembly,’ Corrects Multiple Mutations at Once

Genomic editing holds great potential to treat or cure disease, but the technology continues to have its limitations.

Скрыть анонс
08:21 Arxiv.org CS A barrier or a booster? Familiarity effects on Mandarin emotion prosody recognition using AI-powered voice cloning

arXiv:2609.38794v1 Announce Type: cross Abstract: Emotion prosody perception requires simultaneous processing of acoustic cues and speaker identity. While listeners effortlessly decode natural speech, AI synthetic voices introduce cognitive complexities due to subtle acoustic atypicalities. It remains unclear how these synthetic features interact with a listener's prior social knowledge and memory of a familiar speaker. This study investigated how speech sources (human vs. AI) and speaker familiarity affect emotion recognition accuracy and cognitive load. A within-subject task with Mandarin-speaking adults evaluated behavioral (accuracy, reaction time) and physiological data (heart rate variability). Results showed that human voices yielded significantly higher accuracy and faster processing times than AI voices, while HRV did not significantly differentiate between conditions. These findings show that decoding synthetic speech is gated by top-down social cognition, highlighting

Скрыть анонс
08:21 Arxiv.org CS Tacit-TTS: From Autoregressive Decoding to Masked Prediction for Efficient Transcript-Free Voice Cloning

arXiv:2609.38658v1 Announce Type: cross Abstract: TTS systems with autoregressive semantic modeling have demonstrated strong zero-shot voice cloning performance and rich expressive variation, but their sequential decoding incurs substantial latency. Non-autoregressive alternatives offer much faster generation, yet often rely on more restrictive reference conditioning, such as requiring transcripts of the reference speech during inference. We present Tacit-TTS, an efficient transcript-free zero-shot voice cloning system distilled from IndexTTS2. Our model replaces autoregressive text-to-semantic decoding with masked non-autoregressive generation, introduces training-free acoustic length estimation, and accelerates the flow-matching renderer through ReFlow distillation. Across two English and two Mandarin datasets, Tacit-TTS achieves competitive zero-shot quality while generating speech over 10x faster than IndexTTS2 for utterances longer than 5 seconds. Its transcript-free conditioning

Скрыть анонс
08:21 Arxiv.org CS Making Sense of Animal-to-Human Drug Development Evidence: Stakeholder Practices, Challenges, and Requirements for AI Tools

arXiv:2609.39808v1 Announce Type: new Abstract: Animal models are widely used to study human biology and health interventions, yet translating findings from animal studies to humans remains challenging. Evidence across preclinical and clinical research informs experimental and translational decisions. Artificial Intelligence (AI) tools are increasingly reshaping how this evidence is searched, synthesized, and used, but it remains unclear how they should support the diverse stakeholders involved in assessing animal-to-human evidence. We conducted semi-structured interviews with 13 stakeholders to examine their evidence practices, challenges, and expectations for AI support. We found that stakeholders approach the same incomplete evidence base with different goals, expertise, and heuristics. Participants valued AI particularly for locating, screening, and extracting evidence, but were more cautious about automated interpretation and quality judgments. They emphasized transparency,

Скрыть анонс
08:21 Arxiv.org CS From Knowledge to Legitimacy: A Philosophical Problem Discovery of AI Implementation Readiness in Public Health Disease Surveillance

arXiv:2609.39513v1 Announce Type: new Abstract: Despite being an emerging credible means of using artificial intelligence (AI) for improving disease surveillance via early detection of outbreaks, epidemics prediction and evidence-based decision-making, there continue to be challenges in the use of AI tools in many low- and middle-income countries (LMICs) due to various factors including fragmented health information system, digital inequality, governance problems and institutional incapability. Most of the research conducted so far has concentrated on the efficacy and accuracy of AI in terms of predicting outbreaks, with little focus on other conditions necessary for its deployment. This study adopts a qualitative problem-discovery research design, integrating thematic analysis with philosophical analysis to examine the structural and normative barriers surrounding AI implementation in disease surveillance. The analysis identifies four interrelated dimensions of implementation

Скрыть анонс
08:21 Arxiv.org CS Towards Trustworthy AI for Glioma Diagnosis: A Task-Aware Evaluation of Uncertainty Quantification

arXiv:2609.39429v1 Announce Type: new Abstract: Uncertainty Quantification (UQ) is a key requirement for trustworthy AI in high-stakes medical image analysis. In this work, we evaluate UQ in a multi-task Deep Learning framework for MRI-based glioma diagnosis that performs tumor segmentation and predicts IDH mutation status, 1p/19q co-deletion status, and tumor grade. Monte Carlo Dropout (MCD) is used for a detailed task-aware analysis of predictive, aleatoric, and epistemic uncertainty. We assess MC sample convergence, calibration, error detection, selective prediction, associations with segmentation performance, and the effect of voxel-wise uncertainty aggregation on case-level reliability. We also compare MCD with Deep Ensembles (DE) and Monte Carlo Deep Ensembles (MCDE), examine interactions between segmentation quality and classification, and evaluate a composite trust score integrating segmentation and classification uncertainty. Across tasks, uncertainty estimates supported

Скрыть анонс
08:21 Arxiv.org CS Diffusion-2BC: Hybrid Diffusion and Regression Training for Offline Behavior Cloning in Autonomous Driving

arXiv:2609.38472v1 Announce Type: new Abstract: Behavior cloning provides an offline route to autonomous-driving policy learning, but mean-squared-error regression is poorly matched to demonstrations in which one observation admits several valid actions. Diffusion policies can represent conditional multimodal action distributions, yet their closed-loop performance may be unstable when visual features and control are learned from limited data. This paper presents Diffusion-2BC, which combines a diffusion denoising objective with an auxiliary deterministic behavior-cloning loss over a shared visual encoder. The auxiliary branch is used only during training; inference remains diffusion-based. The proposed method is evaluated in the controlled Claw environment and in bird's-eye-view CARLA navigation, including route-conditioned driving, route-free navigation through multiple intersections, and cross-map evaluation from Town01 to Town02. In the Claw task, Diffusion-2BC reduced the mean

Скрыть анонс
08:21 Arxiv.org CS Memorize, Adapt, Ignore: Diagnosing Robot Learning Mechanisms under Training Data Variation

arXiv:2609.38401v1 Announce Type: new Abstract: Training data variation, whether through designing a domain randomization (DR) scheme in simulation or curating demonstrations for imitation learning, is a primary lever for improving the robustness of robotic manipulation policies. Yet its underlying mechanisms remain poorly understood, and practitioners typically select randomization parameters through expensive trial and error. We investigate these mechanisms through a series of case studies, randomizing object size, color, and type as well as scene lighting and linguistic prompts across settings including pick-and-place RL in ManiSkill and fine-tuning of vision-language-action (VLA) models on LIBERO and RoboTwin. We examine both model behavior and internal representations, using the empirical neural tangent kernel (NTK) as our primary diagnostic tool. We show that the NTK distinguishes a shift in the internal learning mechanism from \textit{memorizing} different situations with

Скрыть анонс
07:00 Bioengineer.org AI Turns Blood Proteins Into a Senescence Score That Predicts Death and Disease

Scientists have unveiled a new artificial intelligence–derived blood test that distills the molecular noise of cellular aging into a single number, one that appears to forecast who will die, who will fall ill, and how quickly the body accumulates the senescent cells that many researchers now consider a driving force behind growing old. The biomarker, […]

Скрыть анонс
06:18 Bioengineer.org MitoQ: The Mitochondria-Targeted Antioxidant That Could Slow Aging

Aging has long been framed as an unavoidable slide toward cellular decay, but a comprehensive new review published in GeroScience argues that one of its most damaging drivers—mitochondrial oxidative stress—may be a target we can actually hit. The review, led by Siyun Kim and Oh Sung Kwon of the University of Connecticut together with colleagues […]

Скрыть анонс
04:36 MedicalDaily.com Proton Therapy Did Not Help Advanced Liver Cancer Patients Live Longer Than Standard Radiation in Phase 3 Trial

In the Phase 3 NRG-GI003 trial, proton therapy did not extend survival over standard radiation in advanced liver cancer. Here is what patients should ask.

Скрыть анонс
02:37 Google news Health Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working - The New York Times

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working  The New York TimesHow a Mass. researcher's lab made a breakthrough in pancreatic cancer treatment  WBURThis Pill Will Change Cancer Treatment Forever  GizmodoFlorida man says new pancreatic cancer drug has provided miracle results  WKMGAIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video  markets.businessinsider.com

Скрыть анонс
02:37 Google news Sci/Tech Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working - The New York Times

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working  The New York TimesHow a Mass. researcher's lab made a breakthrough in pancreatic cancer treatment  WBURThis Pill Will Change Cancer Treatment Forever  GizmodoFlorida man says new pancreatic cancer drug has provided miracle results  WKMGAIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video  markets.businessinsider.com

Скрыть анонс
02:10 Bioengineer.org New Low-Cost Tool Turns Microscope Images Into 3D Models of Plant Stem Cells

Every year, wind and other abiotic forces cause herbaceous crop stems to buckle and snap, a phenomenon known as lodging that significantly reduces yields and poses a major challenge to global food security. The structural failure of a stem is not simply a matter of how tall a plant grows or how thick its stalk […]

Скрыть анонс
01:43 Bioengineer.org Stem Cell Transplant Outperforms Drug Therapy for Younger Middle-Aged Aplastic Anemia Patients

Severe aplastic anemia is one of the most unforgiving diagnoses in hematology. The bone marrow, the factory that manufactures red blood cells, white blood cells, and platelets, simply stops working, leaving patients vulnerable to profound anemia, life-threatening infections, and spontaneous bleeding. For decades, the standard first-line treatment for patients over the age of forty has […]

Скрыть анонс
01:43 Bioengineer.org Oral Drug SUN11602 Speeds Early Nerve Regeneration in Rat Study

Peripheral nerve injuries are among the most stubborn problems in modern medicine. When a nerve is cut, the body launches a slow, energy-intensive repair program that can take months to complete, and in many cases function never fully returns. Now, a team of researchers at the University of Messina in Italy reports that an experimental […]

Скрыть анонс
01:43 MedicalXpress.com Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies by Queen Mary University of London, the University of Oxford and the University of Bristol found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Скрыть анонс
01:35 DiscoverMagazine.com A Gene-Edited Banana Stays Yellow Longer and Is a Step Closer to Grocery Store Shelves

Learn how gene editing keeps sliced bananas yellow longer, and what England’s approval means for bringing the fruit to shoppers.

Скрыть анонс
30.09.2026
23:40 ArsTechnica.com RFK Jr. thinks AI will free us from the "tyranny" of medical facts, expertise

AI is far from a perfect resource. But it seems to hallucinate less than Kennedy.

Скрыть анонс
23:33 Bioengineer.org Leukemia and Lymphoma Patients Fare Similarly After Stem Cell Transplants, Study Finds

For decades, doctors have treated T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma as two faces of the same disease. Both arise from immature T cells, the immune system’s in-training soldiers, and both are driven by the uncontrolled proliferation of lymphoblasts. The conventional distinction was largely anatomical: when the malignant cells crowd the bone marrow […]

Скрыть анонс
22:59 TheNextWeb.com Tokyo court rules the human voice is protected, in a TikTok AI clone case

A Tokyo court ruled on Wednesday that Japanese law protects the human voice. Anime voice actor Kenjiro Tsuda had sued TikTok over videos he says used an AI clone of his voice. He won in part, as the court turned down his request to remove the videos, Agence France-Presse reported. AFP believes the lawsuit is […] This story continues at The Next Web

Скрыть анонс
22:42 News-Medical.Net Nuclear enzyme discovery unlocks new paths to combat breast cancer

One of the major challenges in the treatment of the most common subtype of breast cancer (hormone receptor positive, HR+) is the emergence of resistance.

Скрыть анонс
22:27 Bioengineer.org CRISPR Multiplex Editing Rewires Soybean Flowering Genes to Create Early-Maturing Lines in Just Two Generations

Soybean is one of the world’s most important crops, a cornerstone of plant protein and vegetable oil production, and a crop that European agriculture would dearly love to grow more of. Yet despite decades of breeding effort, the soybean’s cultivation footprint in Europe remains far smaller than its agronomic potential. The reason lies in the […]

Скрыть анонс
22:13 Bioengineer.org How Exercise Rejuvenates Aging Cartilage: Tiny Vesicles Carry a Longevity Signal

For decades, physicians have prescribed aerobic exercise as one of the few reliable ways to protect aging joints, yet the molecular courier service that carries the benefits of a treadmill session from the bloodstream to the cartilage lining our knees has remained largely invisible. A new study published in Nature Aging by Hirotaka Iijima, Fabrisia […]

Скрыть анонс
22:11 Techcrunch.Com OpenAI’s Jev clone could help the frontier lab stop its swarming agents

OpenAI's "Decisions API" is a Jev clone that confirms the importance of fast, cheap intelligence.

Скрыть анонс
21:50 InvestorPlace.com The AI Breakthroughs – and Opportunity – Hiding in Your Doctor’s Office

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Let’s consider some of the recent incredible leaps that AI has made, particularly in healthcare. The past few months of AI development have revolutionized that industry… and barely anyone has noticed. The post The AI Breakthroughs – and Opportunity – Hiding in Your Doctor’s Office appeared first on InvestorPlace.

Скрыть анонс
21:47 Bioengineer.org AI Health Coaches Get Personal: Massive Review Maps How Chatbots Could Tailor Care to You

Large language models have already rewritten the rules of how we search, write, and code. Now, according to a sweeping systematic review published in Artificial Intelligence Review, they are being retooled for something far more intimate: understanding your health, your habits, and your unique circumstances well enough to nudge you toward a better life. A […]

Скрыть анонс
21:47 Bioengineer.org Plant Viruses Already Carry Weapons That Can Blind CRISPR-Cas13

CRISPR-Cas13 has rapidly become one of the most versatile tools in plant biotechnology, offering researchers the ability to target RNA molecules directly rather than editing the genome itself. Because Cas13 cleaves RNA rather than DNA, it promises flexible, reversible control of gene expression and a powerful new line of defense against plant RNA viruses. But […]

Скрыть анонс
21:47 Bioengineer.org CAR-T Therapy May Cost Less Than Stem Cell Transplants Beyond the Price Tag, German Data Suggest

Chimeric antigen receptor T-cell therapy, better known as CAR-T, has been one of the most celebrated breakthroughs in modern cancer medicine. By genetically reprogramming a patient’s own immune cells to hunt and destroy malignant B cells, the therapy has reshaped the outlook for people with diffuse large B-cell lymphoma, an aggressive cancer of the lymphatic […]

Скрыть анонс
21:27 Futurity.org Could humans ever regenerate their brains like these worms?

Researchers have pinpointed several of the genes that make brain regeneration possible in one type of flatworm.

Скрыть анонс
20:53 Bioengineer.org AI Model Borrows From Lookalike Cells to Predict How Tumors Respond to Drugs

Predicting how a patient’s tumor will respond to a particular drug remains one of the most stubborn problems in precision oncology. Two patients can carry the same driver mutation, receive the same targeted therapy, and experience dramatically different outcomes, a phenomenon rooted in the genomic and transcriptomic heterogeneity that defines cancer at the single-tumor and […]

Скрыть анонс
20:53 NYT Science Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Скрыть анонс
20:53 NYT Health Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Скрыть анонс
20:25 MedicalXpress.com New AI platform could help cancer survivors get personalized support between doctor visits

Researchers with Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have created a framework for developing, evaluating and implementing AI tools in cancer survivorship and supportive care, according to a new proof-of-concept study published in the journal Translational Behavioral Medicine.

Скрыть анонс
20:12 Bioengineer.org CRISPR Activation Screen Uncovers Rice Gene That Shields Plants From Fungal Attack

Rice feeds more than half of humanity, yet its harvests are under constant siege from fungal pathogens that destroy crops ranging from seedling fields to ripening panicles. In a study published in Nature Plants, a team led by Jian-Feng Li at Sun Yat-sen University, working with collaborators at the China National Rice Research Institute and […]

Скрыть анонс
18:12 NYT Health Medical Records Firm Uses AI Tool to Expose Flaws that Threaten Patient Privacy

Epic’s engineers deployed an Anthropic tool that exposed security risks that could allow undetected access to millions of patient records.

Скрыть анонс
17:51 IbTimes.co.uk RFK Jr Says Sam Altman Called It 'Malpractice' for Doctors to Diagnose or Prescribe Without Checking AI

Health Secretary Robert F. Kennedy Jr said Sam Altman told him doctors could commit malpractice by failing to check AI, though the claim has not been confirmed by Altman directly.

Скрыть анонс
17:46 MedicalXpress.com Japanese hospital performs first surgery using heart muscle stem cells

A hospital in Japan has carried out the world's first surgery using sheets of commercially available heart muscle stem cells after the groundbreaking therapy was approved this year, one of the surgeons said.

Скрыть анонс
17:34 Wired.com A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos

The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.

Скрыть анонс
16:00 News-Medical.Net Young adults using AI for health questions may screen positive for anxiety and depression

Young adults who use generative artificial intelligence to ask health-related questions are more likely to screen positive for clinically significant anxiety and depression than those not using the AI tool for health issues, according to a new study led by University of Florida researcher Yusen Zhai.

Скрыть анонс
Первая← Предыдущая12345678910Предыдущая →